FDA Gives Fast Track Approval To ZMapp Experimental Ebola Drug ZMapp, the experimental drug for Ebola treatment, has received a Fast Track designation from the FDA. Through this approval, the manufacturer of the drug is hoping to market its product soon. by Rina Marie Doctor
Healthy Living/Wellness ZMapp or faith? What cured Ebola patients? Blood may hold the clue: WHO by Rhodi Lee
Healthy Living/Wellness Experimental Ebola drug ZMapp cures monkeys in clinical trial: Humans, next? by Linda Nguyen
Healthy Living/Wellness Experimental drug used on two infected Americans to wipe out Ebola? by Anu Passary